Clinical Trial Update: Carvedilol and Alverine in Portal Hypertension [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating carvedilol and alverine for portal hypertension is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Portal Hypertension

Drugs mentioned

• Alverine (Alverine citrate)
• CARVEDILOL (Carvedilol)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Hypertension, Portal | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING